Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Shareholders' Equity

v3.25.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series C Conversion
Series B Conversion
Preferred Class B
Common Stock
Common Stock
Series C Conversion
Common Stock
Series B Conversion
Preferred Stock
Preferred Class B
Preferred Stock
Preferred Class B
Series C Conversion
Preferred Stock
Preferred Class B
Series B Conversion
Preferred Stock
Preferred Class C
Additional Paid-in Capital
Additional Paid-in Capital
Series C Conversion
Additional Paid-in Capital
Series B Conversion
Accumulated Other Comprehensive Loss
Retained (Deficit) Earnings
Non-controlling Interest
Non-controlling Interest
Series B Conversion
Common stock, Beginning balance (in shares) at Dec. 31, 2021         26,969,000                          
Preferred stock, Beginning balance (in shares) at Dec. 31, 2021               0     0              
Beginning balance, including noncontrolling interest at Dec. 31, 2021 $ 593,654       $ 270     $ 0     $ 0 $ 258,474     $ 0 $ 334,910 $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) 193,191                             193,191    
Stock options exercised (in shares)         3,000                          
Stock options exercised 206                     206            
Foreign currency translation adjustments 0                                  
Common stock issued under employee stock purchase plan (in shares)         10,000                          
Common stock issued under employee stock purchase plan 783                     783            
Share-based compensation expense 11,376                     11,376            
Payment of dividends to shareholders (25,865)                     17       (25,882)    
Payment of minimum tax withholdings on share-based awards (in shares)         (31,000)                          
Payment of minimum tax withholdings on share-based awards (3,330)                             (3,330)    
Repurchases and retirement of common stock (in shares)         (600,000)                          
Repurchases and retirement of common stock (62,771)       $ (6)                     (62,765)    
Issuance of share-based awards (in shares)         111,000                          
Issuance of share-based awards 0       $ 1             (1)            
Common stock, Ending balance (in shares) at Dec. 31, 2022         26,462,000                          
Preferred stock, Ending balance (in shares) at Dec. 31, 2022               0     0              
Ending balance, including noncontrolling interest at Dec. 31, 2022 707,244       $ 265     $ 0     $ 0 270,855     0 436,124 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) 167,351                             167,351    
Foreign currency translation adjustments 0                                  
Common stock issued under employee stock purchase plan (in shares)         11,000                          
Common stock issued under employee stock purchase plan 800                     800            
Share-based compensation expense 12,012                     12,012            
Payment of dividends to shareholders (24,995)                     18       (25,013)    
Payment of minimum tax withholdings on share-based awards (in shares)         (40,000)                          
Payment of minimum tax withholdings on share-based awards (4,340)                             (4,340)    
Repurchases and retirement of common stock (in shares)         (883,000)                          
Repurchases and retirement of common stock (93,811)       $ (9)                     (93,802)    
Issuance of share-based awards (in shares)         121,000                          
Issuance of share-based awards $ 0       $ 1             (1)            
Common stock, Ending balance (in shares) at Dec. 31, 2023 25,670,663       25,671,000                          
Preferred stock, Ending balance (in shares) at Dec. 31, 2023 0             0     0              
Ending balance, including noncontrolling interest at Dec. 31, 2023 $ 764,261       $ 257     $ 0     $ 0 283,684     0 480,320 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (1,131,228)                             (816,969) (314,259)  
Foreign currency translation adjustments (2,732)                           (2,732)      
Shares issued - acquisition (in shares)         700,000     4,000                    
Shares issued - acquisition 617,128       $ 7             205,510         411,611  
Common stock issued under employee stock purchase plan (in shares)         44,000                          
Common stock issued under employee stock purchase plan 753                     753            
Share-based compensation expense 10,188                     10,188            
Payment of minimum tax withholdings on share-based awards (in shares)         (43,000)                          
Payment of minimum tax withholdings on share-based awards (1,442)                             (1,442)    
Issuance of share-based awards (in shares)         170,000                          
Issuance of share-based awards 0       $ 2             (2)            
Share conversions (in shares)           1,210,000 2,009,000   8,000 (2,000)                
Share conversions   $ 0 $ 29,104     $ 12 $ 20           $ (12) $ 42,296       $ (13,212)
Tax receivable agreement liability and other adjustment $ (164)                     (25)       (139)    
Common stock, Ending balance (in shares) at Dec. 31, 2024 29,761,197       29,761,000                          
Preferred stock, Ending balance (in shares) at Dec. 31, 2024 0     10,088       10,000     0              
Ending balance, including noncontrolling interest at Dec. 31, 2024 $ 285,868       $ 298     $ 0     $ 0 $ 542,392     $ (2,732) $ (338,230) $ 84,140